SYMBOL: BCAC
Company: Brookline Capital Acquisition Corp.
Company: Brookline Capital Acquisition Corp.
SYMBOL
: BCACStage: 2. Seeking Target
Size: $71.364.297
Latest Price: $10,21
Previous close: $10,65
All time high price: $11,07
Volume: 51.551
Average volume:
FOLLOW SPAC
DISCOVER NEW FRIENDS
GET AHEAD OF THE GAME
Brookline Capital Acquisition Corp. is listed on the stock exchange with the ticker / Symbol BCAC,
BCAC SPAC all time high was $11,07 and the lowest price in the last 52 week was: ,
the current BCAC stock price is $10,21. BCAC has an overall market cap of: $71.364.297.
The latest volume was: 51.551.
BCAC is currently in stage: 2. Seeking Target.
You can read all about BCAC and it’s information about the SPAC, news, SEC filings and more on our special data platform.
Want to know more about BCAC and Brookline Capital Acquisition Corp.? Join us today.
BCAC SPAC all time high was $11,07 and the lowest price in the last 52 week was: ,
the current BCAC stock price is $10,21. BCAC has an overall market cap of: $71.364.297.
The latest volume was: 51.551.
BCAC is currently in stage: 2. Seeking Target.
You can read all about BCAC and it’s information about the SPAC, news, SEC filings and more on our special data platform.
Want to know more about BCAC and Brookline Capital Acquisition Corp.? Join us today.
- Bespoke Capital Acquisition Corp. Announces Listing on Nasdaq – Yahoo Finance
- Vintage Wine Estates, One of the Fastest Growing U.S. Wine Producers, to Become a Public Company – GlobeNewswire
- Special Purpose Acquisiton Companies (SPACS) list 2021 – MarketBeat
- Current Vitae price: $3.600 – CryptoCoin.News
- Canadian SPACs: Rising From The Ashes – Seeking Alpha
- Bespoke Capital Acquisition Corp. Files Preliminary Prospectus for US$350000000 Initial Public Offering – Canada NewsWire
- Bison Capital Acquisition Corp. Announces Record and Meeting Dates for the Special Meeting of Shareholders to Approve Business Combination with Xynomic Pharmaceuticals, Inc. – GlobeNewswire
- Bison Capital Acquisition Corp. Clarifies Information of Its Chairman and President – GlobeNewswire
- Bison Capital Acquisition Corp. and Xynomic Pharmaceuticals, Inc. Announce Signing of Definitive Merger Agreement – GlobeNewswire
- Bison Capital Acquisition Corp. Completes $52500000 Initial Public Offering – GlobeNewswire
- Bison Capital Acquisition Corp. Announces Pricing of $52.5 Million Initial Public Offering – GlobeNewswire
- Russia struggles to unleash clean energy potential – Financial Times
- Four ways business can help everyone in the digital revolution – Financial Times
- Beijing’s migrants no longer welcome as city caps population – Financial Times
- Unusual homes for young professionals, from yurts to horseboxes – Financial Times
[finviz ticker=BCAC]